Correlation Between Unicycive Therapeutics and BWV
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and BWV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and BWV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and BWV, you can compare the effects of market volatilities on Unicycive Therapeutics and BWV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of BWV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and BWV.
Diversification Opportunities for Unicycive Therapeutics and BWV
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Unicycive and BWV is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and BWV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BWV and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with BWV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BWV has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and BWV go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and BWV
If you would invest 51.00 in Unicycive Therapeutics on August 31, 2024 and sell it today you would earn a total of 17.00 from holding Unicycive Therapeutics or generate 33.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.55% |
| Values | Daily Returns |
Unicycive Therapeutics vs. BWV
Performance |
| Timeline |
| Unicycive Therapeutics |
| BWV |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Unicycive Therapeutics and BWV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and BWV
The main advantage of trading using opposite Unicycive Therapeutics and BWV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, BWV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BWV will offset losses from the drop in BWV's long position.| Unicycive Therapeutics vs. Cue Biopharma | Unicycive Therapeutics vs. Eliem Therapeutics | Unicycive Therapeutics vs. Inhibrx | Unicycive Therapeutics vs. Molecular Partners AG |
| BWV vs. Virax Biolabs Group | BWV vs. Revelation Biosciences | BWV vs. Kiora Pharmaceuticals | BWV vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |